CLU (Clusterin) variants and mutations

CLU (also known as Clusterin) is a human protein-coding gene encoding a clusterin protein. It acts as an extracellular chaperone and participates in lipid transport, complement regulation, apoptotic-cell clearance, and responses to tissue injury. Common variation near CLU influences late-onset Alzheimer disease risk, and altered expression is observed in cardiovascular disease and cancer. This analysis covers 737 CLU variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes Alzheimer disease, dementia, and late-onset Alzheimers disease. Example CLU variants include M1?, M2V, and T4A.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable CLU variants

Examples include M1?, M2V, T4A, T4I, L5A, L6Q, L6V, F8L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.